News & Events

News Releases

August 8, 2008

Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate

January 5, 2010

Icon Bioscience Initiates Phase 2/3 Pivotal Clinical Study of Novel Ophthalmic Drug Candidate

May 4, 2010

Icon to Present Clinical Data on Verisome Technology in Cystoid Macular Edema at the ARVO Annual Meeting

December 7, 2011

Icon Appoints Murahashi Vice President, Clinical Development

January 3, 2013

Icon’s Melphalan Intraocular Injection Granted U.S. Orphan Drug Designation For the Treatment of Retinoblastoma


My Canadian Pharmacy is an informative service. All the information should not be used in the purposes to establish a diagnosis and prescribe a treatment plan. Our company is a vendor, not a drug manufacturer. We cooperate with drug manufacturers who distribute their products to us. We have no relation with Icon Bioscience and Verisome. They move to another domain. We bear no responsibility for any damage brought to your health. All the questions related to the drug quality should be addressed to the drug manufacturer directly.